NovaBay Pharmaceuticals Inc. (NBY) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    NovaBay Pharmaceuticals I...

    AMEX: NBY · Real-Time Price · USD
    1.79
    0.14 (8.48%)
    At close: Aug 29, 2025, 3:59 PM
    1.77
    -1.40%
    After-hours: Aug 29, 2025, 07:58 PM EDT

    NovaBay Pharmaceuticals Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -7.1M -9.64M -10.61M -5.82M
    Depreciation & Amortization
    		 381K 203K 483K 119K
    Stock-Based Compensation
    		 148K 291K 220K 1.15M
    Other Working Capital
    		 -419K 134K 388K -84K
    Other Non-Cash Items
    		 1.98M 4.26M 2.72M -4.62M
    Deferred Income Tax
    		 n/a n/a n/a n/a
    Change in Working Capital
    		 -595K 750K 533K -38K
    Operating Cash Flow
    		 -5.18M -4.13M -6.65M -9.19M
    Capital Expenditures
    		 -6K -19K -112K -52K
    Cash Acquisitions
    		 1.07M n/a n/a -11.99M
    Purchase of Investments
    		 n/a n/a n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a n/a n/a
    Other Investing Acitivies
    		 n/a n/a n/a -11.99M
    Investing Cash Flow
    		 1.06M -19K -112K -12.04M
    Debt Repayment
    		 -1.49M 1.53M -105K 105K
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 132K 384K 1.7M 16.68M
    Financial Cash Flow
    		 1.5M 1.91M 4.63M 16.79M
    Net Cash Flow
    		 -2.49M -2.24M -2.13M -4.45M
    Free Cash Flow
    		 -5.19M -4.15M -6.77M -9.24M

    Add to Watchlist